(Press-News.org) A poorly characterized protein, historically thought to be a chaperone or enzyme, may actually be a key player in prostate cancer. In a systematic CRISPR screen, scientists from Arc Institute, UCSF, and the Fred Hutchinson Cancer Center have identified PTGES3, known as the third prostaglandin E synthase protein as an unexpected regulator of the androgen receptor. This discovery, published November 5 in Nature Genetics, not only redefines PTGES3’s biological role in regulating gene expression, but also reveals a promising new target for treating aggressive prostate cancers resistant to current hormone therapies.
The research team made the association after creating a fluorescent tag that tracks androgen receptor levels in real time. The androgen receptor is a hormone-sensing protein that normally helps develop and maintain the prostate. Androgen receptor activity is highly amplified in prostate cancer cells and drives aggressive tumor progression, making it a main target of current treatments. This tagging innovation allowed scientists to conduct genome-wide CRISPR screens to identify which genes are essential for maintaining androgen receptor levels in aggressive prostate cancer cells.
During the screens,researchers turned off genes one-by-one to see which caused the glowing androgen receptor protein to disappear. The screens confirmed well-known androgen receptor regulators like HOXB13 and GATA2––validating the approach––but also revealed unexpected candidates including PTGES3. Since PTGES3 was the only one of three related prostaglandin-synthesizing enzymes to affect androgen receptor levels, results suggest it may not function as the enzyme it was thought to be after all.
"Our study illustrates the power of CRISPR approaches to take a quantitative unbiased approach to discover something new about a well-studied protein," says senior author Luke Gilbert (X: @LukeGilbertSF), an Arc Institute Core Investigator and an Associate Professor of Urology at the UCSF School of Medicine. “We were initially interested in identifying enzymes that might regulate androgen receptor biology because they're druggable, but we ended up with PTGES3, a protein that as far as we can tell isn't an enzyme and had a profound effect on the androgen receptor."
To further investigate PTGES3’s potential role in prostate cancer, the research team analyzed patient data, revealing people with high PTGES3 expression had significantly poorer outcomes when treated with hormone therapy. In mouse studies, suppressing PTGES3 delayed tumor growth and reduced androgen receptor levels in tumors, suggesting it could represent a new therapeutic target for treatment-resistant cancers.
The researchers demonstrated that in cancer cells, PTGES3 actually works through dual mechanisms: functioning as a co-chaperone that helps stabilize the androgen receptor protein in the cytoplasm of the cell, and as a nuclear co-factor that allows the androgen receptor to bind to DNA and turn on its target genes. If the androgen receptor is driving prostate cancer progression, then the researchers provide evidence that tumor growth may be supported by, or even dependent on PTGES3’s assistance.
“Previous attempts to modulate transcription factor function for therapy have focused on DNA binding domains and transcription activation domains. Targeting regulators of transcription factor stability, on the other hand, has received less attention," says first author Haolong Li, who conducted the work at UCSF and is currently an Assistant Professor at Fred Hutch. “Our study could serve as a template for understanding other important transcription factors across different hormone-driven cancer types. Going forward there are upwards of 20 transcription factors across oncology research that could benefit from this approach.”
The research team is now working to understand the structural details of how PTGES3 interacts with the androgen receptor. Their long-term goal is to develop therapeutics targeting this interaction, potentially using protein degradation strategies already showing promise in clinical trials.
The other senior author on this study, Felix Feng, Professor of Radiation Oncology, Urology, and Medicine, and Vice Chair of Translational Research at the UCSF Helen Diller Family Comprehensive Cancer Center, passed away last December. “We miss Felix deeply and hope this work is part of his legacy,” says Gilbert.
###
Research reported in this article was supported by the National Institutes of Health, the Prostate Cancer Foundation, the Department of Defense Prostate Cancer Research Program, the Howard Hughes Medical Institute, the Swedish Research Council, the UCSF Benioff Initiative for Prostate Cancer Research, and Arc Institute.The researchers have filed patent applications related to targeting PTGES3.
Li, H., Melnyk, J. E., Fu, B. X. H., Shrestha, R., Zhang, M., Sjöström, M., Feng, S., Anderson, J. A., Han, W., Chesner, L. N., Shin, H. J., Farsh, T., Suarez, H. J., Nath, S., Chou, J., Das, R., Egusa, E. A., Zhu, J., Winters, A., Maheshwari, A., Hua, J. T., Alshalalfa, M., Chen, W. S., Calvert, M., Davicioni, E., Kishishita, A., Barpanda, A., Liu, T., Wiita, A. P., Stohr, B. A., Siddiqui, J., Huang, B., Small, E. J., Shokat, K. M., Nelson, P., Quigley, D. A., Wasmuth, E. V., Gilbert, L. A., & Feng, F. Y. (2025). Genome-wide CRISPR screens identify PTGES3 as a novel AR modulator. Nature Genetics. DOI: 10.1038/s41588-025-02388-8
Arc Institute (X: @arcinstitute) is an independent nonprofit research organization located in Palo Alto, California, that aims to accelerate scientific progress and understand the root causes of complex diseases. Arc's model gives scientists complete freedom to pursue curiosity-driven research agendas and fosters deep interdisciplinary collaboration. The Institute operates in close partnership with Stanford University, the University of California, Berkeley, and the University of California, San Francisco.
END
UNIVERSITY PARK, Pa. — Ancient trees may have played a key role in regulating Earth’s climate during the last ice age — by breathing less efficiently.
A new study, led by a researcher at Penn State and published today (Nov. 5) in the journal Nature Geoscience, examined chemical fingerprints in subfossil wood, or preserved trees, from across North America to understand how plants responded to the low carbon dioxide (CO2) levels and cooler ...
Key points
Viruses have the ability to ‘do so much with so little’ when they infect and ‘take over’ our cells
Understanding how small viruses can do so much has been a major challenge
Researchers have found an answer, which could change how we view viral biology
New antivirals and vaccines could follow the discovery by Australian researchers of strategies used by viruses to control our cells.
Led by Monash University and the University of Melbourne, and published in Nature Communications, the study reveals how rabies virus manipulates so many cellular processes despite being armed ...
The most sophisticated modelling to date forecasts that under the current global emissions pathway the Great Barrier Reef could lose most of its coral by the end of the century, but curbing climate change and strategic management will help coral resilience.
A research team led by The University of Queensland simulated different future climate scenarios driven by a range of plausible global emissions trajectories.
Dr Yves-Marie Bozec from UQ’s School of the Environment said the comprehensive modelling of individual corals included ...
A study published in the journal Nature Climate Change by an international team of scientists, from the IBS Center for Climate Physics (ICCP) at Pusan National University in South Korea, presents new evidence that ocean turbulence and a process known as “horizontal stirring” will increase dramatically in the Arctic and Southern Oceans due to human-induced Global Warming and decreasing sea ice coverage.
“Shaken, not stirred” - it is widely known how James Bond prefers his Martinis. Stirring works by stretching a fluid into thin streaks, which eventually helps to create turbulence, ...
Like the astronomical explosion that kickstarted the universe, bowel cancer has a “Big Bang” moment which determines how it will grow, according to new research from Cancer Research UK and Wellcome Trust-funded scientists.
Researchers at The Institute of Cancer Research, London, Fondazione Human Technopole in Milan and Chalmers University of Technology in Sweden have found that the “Big Bang” moment for bowel cancer is created by cancer cells successfully hiding themselves from the immune system – a process called immune escape.
During this process, bowel cancer cells disrupt genes which allow the cancer to be detected by the ...
A new study led by the University of Michigan shows that changes in climate are also changing the size of fishes in Michigan's inland lakes. Using data that covered 75 years and nearly 1,500 lakes, researchers have shown that, for several species, old and young fish in 2020 were significantly smaller than their typical size in 1945.
"Climate change is altering the size of different organisms around the world, including fishes in lakes here in Michigan," said Peter Flood, a postdoctoral research fellow at the U-M School for Environment and Sustainability, or SEAS. "And most of those changes we're seeing in Michigan fishes are declines in size through time."
Flood ...
Elevated carbon dioxide levels generated as a result of climate change could significantly increase the temperatures found within the canopies of the world’s woodlands and forests, new research has suggested.
A study by researchers from the UK, Ghana and the USA used thermal imaging technology and other sensors to measure the leaf temperatures found at CO2 levels forecast to occur in 2050.
It found that temperatures within the forest canopies rose by around 1.3°C as a direct consequence of increases in CO2 – from an average of 21.5°C under current conditions to 22.8°C at the predicted 2050 ...
A commonly prescribed antibiotic could help reduce the risk of some young people developing schizophrenia, new research suggests.
Experts found that patients of adolescent mental health services who were treated with the antibiotic doxycycline were significantly less likely to go on to develop schizophrenia in adulthood compared with patients treated with other antibiotics.
Experts say the findings highlight the potential to repurpose an existing, widely used medication as a preventive intervention ...
Delta.g, the UK quantum technology company pioneering quantum gravity sensing for subsurface intelligence, today announced the appointment of Ewen Stevenson as Chair of its Board of Directors, effective immediately.
Ewen Stevenson is a veteran banker with over 20 years of senior management experience and a record in strategic transformation, value creation, innovation, and leadership. He is currently Chair of Serendipity Capital who led Delta.g’s recently closed seed funding round. Prior to Serendipity Capital, he served as Group Chief Financial Officer of HSBC Holdings, following four years as Group Chief Financial Officer of The Royal Bank of Scotland. Prior ...
Because policies to address pollution are costly to implement and impose social burdens, it is important to understand the full benefits of pollution-reducing programs. An article in Health Economics provides compelling evidence that one such program offered considerable benefits for infant health, especially in vulnerable populations.
Based on an analysis of more than a decade of US birth records, the research shows that the Nitrogen Oxide Budget Trading Program—a cap-and-trade initiative to reduce ozone pollution—significantly improved infant health outcomes, particularly among Black, low-income, and single mothers.
The program ...
